SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Stressgen (VSE: SSB)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: William Marsh who wrote (164)4/19/2001 6:29:37 PM
From: Heat Shock  Read Replies (1) of 236
 
Hi William,

Hope you are well. I'm looking further out than this year. We have many factors in the next 2.5 years. I'm looking at 2004 for first sales. If the orphan drug status gets sales in late 2003, all the better. If this new "pharma dealer" employee gets a good deal with Merck or someone 1Q, 2Q 2002, what price will we see? I expect a runup the year before PIII approval- during maybe 2003?

Of course a long recession could affect it. Maybe investors go off biotechs. Or a cancer vaccine story on the front page of Time and Newsweek could precipitate a inter-nut-like rocket to galactic prices.

We live in interesting times.

Best regards,
Heat.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News